Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

 


EDITOR - IN - CHIEF

Dimitrios H. Roukos, MD Biosketch profile

 Associate Professor, Dept. of Surgery
Personalized Cancer Medicine, Biobank
Translational Research Leader in
European Network of Excellence (EUNE) for Gastric Cancer

Ioannina University School of Medicine
451 10 Ioannina , Greece
T: +30 26510 07423, F: +30 26510 07094
email: droukos@cc.uoi.gr

Papers: PubMed  Roukos d ; Citations: >2.353 (h=37)
Total Impact factor: ~ 800
Dr. D. Roukos has graduated from Athens University School of Medicine, Greece. He underwent specialist training in surgery at the J.W.Goethe-University Hospital in Frankfurt a.M., Germany where received his Doctorate (Dr.med). He moved back to Greece and since 1990 works at the Ioannina University School of Medicine.
Currenr Research
2000 - today

 

 PERSONALIZED MEDICINE & CANCER (breast, gastric, colorectal). .
 Current, standard, conventional single-gene concept limitations guide Prof. Roukos switch to a global understanding of cancer genetics and signalling pathways network.  

 Integrating clinical and personal genomics data and systems biology advances into network modelling towards a genotype-phenotype-based high-quality personalized practice (HQPP).
1983 - 2000 Clinical research, contribution, principal investigator and publication of retrospective and prospective studies, onconvnetional single protein-coding genes. 

 
INNOVATION
Year
 Articles published for the first time
  Author(s) – Journal.
2010

Novel clinico-genome network odelling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH. Expert Rev Mol Diagn 2010; 10(1): 33-48
2008

Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery.

Roukos DH. Expert Rev Mol Diagn 2008 Sept; 8(5): 587–597.

2008
Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.

Roukos DH. Expert Rev Mol Diagn 2008; 8(1): 29-39.

2007

Individualized preventive and therapeutic management of hereditary breast ovarian cancer .

Roukos DH et al. Nat Clin Pract Oncol 2007; 4 (10) : 578–590

 
1998

Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept : a prospective long-term follow-up study.

 

Roukos DH, t al. Surgery. 1998 ; 123(5):573-8.

International Recognition
1998 -
today

INVITED PAPERS – INVITED SPEAKER –Plenary sessions (International Scientific meetings)

•  Editorials (20), perspectives (4), reviews.

•  KEYNOTE PRESENTATIONS , Lectures in World Congresses and International Meetings (26).

• International Experts Consensus Panel Member (Kyoto, Breast cancer 2009; Krakow (Poland) gastric cancer 2009, Seoul (Korea), Gastric Cancer 1999). 
•  Associate Editor (BMC Cancer), editorial board member and active reviewer in multiple Journals.
•  Reviewer of International Grants (>8),
 
Highlights of publications:
 
 
   
   

Find San Jose Dentist, Oakland Dentist, Fremont Dentist, Palo Alto Dentist, Walnut Creek Denti and Alameda Dentist at DoctorsImprovingHealthcare.org.

ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 February 2010